Cardiovascular Health Effects of Flavanol Rich Chocolate (CHOC)

June 16, 2011 updated by: Wageningen University
In the CHOC study the investigators will examine the effect of chocolate flavanols on vascular function, inflammation, oxidative stress and markers of endothelial function. The effects of both acute consumption and prolonged consumption will be studied. The secondary objectives are to investigate if daily intake of chocolate flavanols for 4 weeks will improve the response to a high fat/high energy challenge.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Wageningen, Gelderland, Netherlands, 6703HD
        • Wageningen universiteit division of human

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male
  • 45-70 years old
  • BMI between 25 and 32 kg/m2

Exclusion Criteria:

  • Urine glucose concentrations outside normal ranges (> 0,25 g/l)
  • Fasting blood glucose < 7.0 mmol/L)
  • Systolic Bp > 160 mmHg or diastolic Bp > 100 mmHg
  • Blood Hb values below 8.4 mmol/L
  • Allergic to cow milk, dairy products or chocolate
  • Vegetarian
  • Tobacco smoker
  • Diagnosed with any long-term medical condition (e.g., diabetes, hemophilia, cardiovascular disease, anemia, gastrointestinal disease, renal failure)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: High flavaonol chocolate
chocolate high in flavanols
Milkshake with 95g fat
Placebo Comparator: Low flavanol chocolate
Milkshake with 95g fat
chocolate low in flavanols

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 0, 4wk
0, 4wk
FMD
Time Frame: 0, 4wk
0, 4wk
PWA
Time Frame: 0, 4wk
0, 4wk

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
leukocyte count and activation
Time Frame: 0, 4wk
0, 4wk
PBMC gene expression
Time Frame: 0, 4wk
0, 4wk
Markers of inflammation and ED
Time Frame: 0, 4wk
0, 4wk
Blood pressure
Time Frame: 0 and 2h
acute study part
0 and 2h
FMD
Time Frame: 0 and 2hrs
acute study part
0 and 2hrs
PWA
Time Frame: 0 and 2 hrs
acute study part
0 and 2 hrs
Leukocyte count and activation
Time Frame: 0 and 2 hrs
acute study part
0 and 2 hrs
PBMC gene expression
Time Frame: 0 and 2 hrs
acute study part
0 and 2 hrs
markers of inflammation and ED
Time Frame: 0 and 2hrs
acute study part
0 and 2hrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Michael Müller, Prof.Dr, Chair Department of human nutrition NMG group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

February 15, 2011

First Submitted That Met QC Criteria

March 3, 2011

First Posted (Estimate)

March 4, 2011

Study Record Updates

Last Update Posted (Estimate)

June 17, 2011

Last Update Submitted That Met QC Criteria

June 16, 2011

Last Verified

June 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • NL33506.081.10

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endothelial Dysfunction

Clinical Trials on High flavanol chocolate

Subscribe